A Prospective, Randomized Trial Comparing Lymphoblastoid to Recombinant Interferon Alfa 2A As Therapy for Chronic Hepatitis C
Maria Grazia Rumi(University of Milan), Massimo Colombo(University of Milan), Alessandra Russo(University of Trento), M. L. Parravicini(University of Milan), Maria Francesca Donato(University of Milan), R. Romeo(Ospedale Maggiore), R. Soffredini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), E. Del Ninno(University of Milan), Judith C. Wilber(University of Milan)
Cited by 56
Related Papers
Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
|Nature Microbiology|2019|1k
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
|Hepatology|2016|710
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
|Gastroenterology|2004|607